Dentium Co., Ltd. (145720) AI Stock Analysis

Dentium Co., Ltd.

(Korea Exchange:145720)

Select Model

Rating:61Neutral

Price Target:KRW 42,569.00▲(6.56% Upside)

Action:initiatedcoverage

Date:11/02/26

The score is primarily constrained by weak cash generation and recurring negative free cash flow, despite a solid balance sheet and improving earnings. Positive technical momentum and an attractive P/E ratio provide secondary support.

Positive Factors

Healthy Operating MarginsStrong gross, operating, and EBITDA margins indicate that Dentium retains meaningful economics in its dental-device operations. This profitability buffer can support ongoing investment, help absorb cost pressure, and provide resilience over the next several quarters if revenue growth remains uneven.

Negative Factors

Profitability DeteriorationThe sharp decline in net margin and return on equity shows that recent revenue is converting into substantially less profit and shareholder return. If this deterioration persists, it could weaken internal reinvestment capacity and reduce the earnings power of an otherwise profitable operating model.

Dentium Co., Ltd. (145720) vs. SPDR S&P 500 ETF (SPY)

Market Cap: KRW 333.49B
Dividend Yield: 1.49%
Average Volume (3M): 22.81K
Price to Earnings (P/E): 11.3
Beta (1Y): 0.11
Revenue Growth: -6.55%
EPS Growth: -58.05%
Country: KR
Employees: 876
Sector: General
Sector Strength: 55
Industry: Medical - Instruments & Supplies

Dentium Co., Ltd. Business Overview & Revenue Model

Company Description

Dentium Co., Ltd., based in Seoul, South Korea, is a prominent global manufacturer and supplier of cutting-edge dental implant solutions. The company's extensive product range encompasses various dental implant systems, such as Superline, Implantium,...

Dentium Co., Ltd. Financial Statement Overview

Summary

Recent revenue and earnings improved, and the balance sheet is solid with moderate leverage. However, recurring negative free cash flow and weak cash conversion materially reduce financial quality.

Income Statement

68Positive

Balance Sheet

72Positive

Cash Flow

25Negative

Financial statement breakdown
Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	348.09B	346.45B	407.81B	393.19B	355.87B	291.53B
Gross Profit	215.08B	205.82B	260.25B	278.84B	260.68B	193.15B
EBITDA	96.21B	87.39B	126.72B	162.80B	144.14B	94.00B
Net Income	30.49B	16.80B	72.71B	96.52B	86.07B	55.48B
Balance Sheet
Total Assets	986.84B	933.07B	894.43B	773.77B	674.58B	570.20B
Cash, Cash Equivalents and Short-Term Investments	75.93B	88.51B	109.83B	86.91B	72.05B	65.84B
Total Debt	300.44B	288.04B	256.73B	208.76B	208.56B	192.97B
Total Liabilities	392.20B	371.46B	340.92B	309.90B	301.42B	279.10B
Stockholders Equity	596.09B	562.84B	554.67B	464.60B	373.88B	291.84B
Cash Flow
Free Cash Flow	-20.73B	-43.45B	14.81B	20.84B	-7.10B	45.07B
Operating Cash Flow	37.75B	9.55B	36.46B	64.99B	47.01B	74.11B
Investing Cash Flow	-67.18B	-59.13B	-65.33B	-47.20B	-49.03B	-21.78B
Financing Cash Flow	9.45B	26.89B	35.39B	-2.79B	8.77B	-24.06B

Dentium Co., Ltd. Technical Analysis

Technical Analysis SentimentPositive

Last Price39950.00

Price Trends

50DMA38127.00Positive

100DMA39496.00Positive

200DMA44741.79Negative

Market Momentum

MACD451.54Negative

RSI56.85Neutral

STOCH70.69Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For KR:145720, the sentiment is Positive. The current price of 39950.00 is above the 20-day moving average (MA) of 39300.00, above the 50-day MA of 38127.00, and below the 200-day MA of 44741.79, indicating a neutral trend. The MACD of 451.54 indicates Negative momentum. The RSI at 56.85 is Neutral, neither overbought nor oversold. The STOCH value of 70.69 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for KR:145720.

Dentium Co., Ltd. Peers Comparison

Overall Rating

UnderperformOutperform

Sector (55)

Financial Indicators

KR:145720 against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
KR:145720	61Neutral	KRW 347.97B	11.30	―	1.49%	-6.55%	-58.05%
Sector *	55Neutral	$6.65B	3.83	-15.92%	6.20%	10.91%	7.18%

* General Sector Average

Performance Comparison

KR:145720 and its peers over the selected period
Show on chart	Ticker	Company Name	Price	Change	% Change
	KR:145720	Dentium Co., Ltd.	39950.00	-15896.82	-28.47%
	KR:042520	Hans Biomed Corp	17200.00	-10800.00	-38.57%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Oct 28, 2026

Dentium Co., Ltd. AI Stock Analysis